Search results

Results 1 – 20 of 91
Advanced search

Search in namespaces:

There is a page named "Ascrinvacumab" on Wikipedia

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • Ascrinvacumab (PF-03446962) is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Pfizer Inc. Statement On A Nonproprietary...
    1 KB (37 words) - 17:10, 5 February 2023
  • Thumbnail for Myostatin
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    48 KB (5,322 words) - 21:51, 13 July 2024
  • Thumbnail for Transforming growth factor beta
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    70 KB (8,486 words) - 02:10, 19 August 2024
  • Thumbnail for GDF15
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    13 KB (1,339 words) - 17:49, 3 August 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    Carcinoembryonic antigen (CEA) gastrointestinal cancers (diagnosis) Ascrinvacumab mab human activin receptor-like kinase 1 cancer Aselizumab mab humanized...
    136 KB (4,020 words) - 07:14, 15 August 2024
  • Thumbnail for Follistatin
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    19 KB (2,169 words) - 07:41, 4 August 2024
  • Thumbnail for Anti-Müllerian hormone
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    41 KB (4,871 words) - 06:27, 18 June 2024
  • Thumbnail for Transforming growth factor beta superfamily
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    7 KB (595 words) - 14:53, 18 November 2022
  • Thumbnail for Activin and inhibin
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    26 KB (2,557 words) - 08:59, 5 August 2024
  • Thumbnail for TGF beta 1
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    19 KB (2,290 words) - 20:43, 26 March 2024
  • Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    20 KB (2,098 words) - 00:36, 28 November 2023
  • Thumbnail for Noggin (protein)
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    19 KB (2,327 words) - 01:11, 11 August 2024
  • Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    6 KB (596 words) - 05:15, 1 January 2024
  • Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    33 KB (3,537 words) - 19:46, 18 July 2024
  • Thumbnail for GDF11
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    34 KB (3,979 words) - 20:36, 23 June 2024
  • Thumbnail for Thrombospondin 1
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    19 KB (2,345 words) - 04:52, 3 June 2024
  • Thumbnail for Bone morphogenetic protein 4
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    44 KB (5,478 words) - 21:37, 11 August 2024
  • Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    10 KB (1,271 words) - 15:32, 3 December 2023
  • Thumbnail for ACVR1
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    9 KB (1,052 words) - 01:13, 22 January 2024
  • Thumbnail for TGFBR3
    Avotermin BMP (10) Cetermin GDF (2 (BMP9)) TGFβ (1, 2, 3) Antibodies: Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors:...
    13 KB (1,632 words) - 06:39, 20 April 2024
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)